InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（3 笔）
内部人交易记录
董事已披露买入
3
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Tannenbaum Renee P, Administratrice. Director active across 3 companies, notably Zogenix, INC.. In total, 12 filings have been recorded. Split: 3 buys · 3 sells. Total volume traded: €411k. Activity tracked since 1 June 2021. The latest transaction was filed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Tannenbaum Renee P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
4,357 股0Common StockSEC:0001543174-26-000003:0
1,800 股@ US$81.1551.6% 占其流量Common StockSEC:0001543174-25-000006:0
4,336 股0Common StockSEC:0001543174-25-000002:0
10,000 股@ US$3.422474.8% 占其流量Common StockSEC:0000950170-24-136725:0
标准退出：2025年3月12日 (T+90)
4,410 股0Common StockSEC:0001543174-24-000005:0
2,000 股@ US$63.8748.4% 占其流量Common StockSEC:0001543174-24-000002:0
6,865 股0Common StockSEC:0001104659-23-064160:0
6,400 股@ US$1.71525.2% 占其流量Common StockSEC:0001628280-22-025101:0
标准退出：2022年12月14日 (T+90)
13,346 股0Common StockSEC:0001415889-22-003266:0
32,567 股Common StockSEC:0000899243-22-010303:0
5,305 股@ US$11.7244.1% 占其流量Common StockSEC:0001375151-21-000102:0
5,000 股@ US$17.049555.9% 占其流量Common StockSEC:0001375151-21-000072:0
标准退出：2021年8月30日 (T+90)
12 条申报中的 12 条
About Tannenbaum Renee P
Renee P. Tannenbaum is an Administratrice at ANI Pharmaceuticals INC, Zogenix, INC. and Cardiff Oncology, Inc. Across the 12 filings available, the sampled filings cover the period from 2021-06-03 to 2026-06-10, with EUR 113335 of buys and EUR 298054 of sells, and the most common transaction nature is Attribution.
